Table 2.
The antigen epitopes for vaccine construction.
| NO. | Antigen epitope | Variant epitope | Type | Variation rate a |
|---|---|---|---|---|
| 1 2 3 4 5 6 7 8 |
TTRTQLPPAY RTRTQLPPAY LPFFSNVTWF LPIGINITRF FPNITNLCPF LQSYGFQPTY QPYRVVVLSF NTSNQVAVLY |
RTRTQLPPAY LQSYGFQPTY |
CTLEs | 25.0% |
| 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 |
IGINITRFQTLHRSY NDGVYFASTEKSNII GINITRFQTLHRSYL VEKGIYQTSNFRVQP EKGIYQTSNFRVQPT KGIYQTSNFRVQPTE QTSNFRVQPTESIVR TSNFRVQPTESIVRF NRALTGIAVEQDKNT FGGFNFSQILPDPSK RAAEIRASANLAATK RAAEIRASANLAAIK AAEIRASANLAATKM AAEIRASANLAAIKM EPQIITTDNTFVSGN YEPQIITTDNTFVSG |
IGINITRFQTLHRSY NDGVYFASTEKSNII GINITRFQTLHRSYL RAAEIRASANLAAIK AAEIRASANLAAIKM YEPQIITTDNTFVSG |
HTLEs | 37.5% |
| 25 26 27 28 29 30 31 32 33 |
CVNLTTRTQLPP VRGLPQGFSALE RQIAPGQTGKIA VRQIAPGQTGTI NFNFNGLTGTGV SKVGGNYNYRYR ECDIPIGAGICA HVTYVPAQEKNF NNTVYDPLQPEL |
VRGLPQGFSALE VRQIAPGQTGTI NFNFNGLTGTGV |
LBEs | 33.3%7 |
| 34 35 36 37 |
YDPLQPELDS NSVA KNHTSP NHTSP |
NSVA KNHTSP NHTSP |
CBEs | 75.0% |
a
Among the corresponding types of epitopes, the proportion of epitopes appearing in the virus variant.